<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>The Malaria community of South Africa</title><link>http://www.bizcommunity.com//196/152.html</link><description>South Africa Malaria news</description><ttl>15</ttl><category>Malaria news - South Africa</category><image><url>http://www.bizcommunity.com/res/img/11/logo5.gif</url><title>Bizcommunity.com</title><link>http://www.bizcommunity.com/</link></image><language>en-us</language><pubDate>Mon, 13 Feb 2012 07:29:30 +0200</pubDate><item><title>PMBs here to stay, court rules</title><link>http://www.bizcommunity.com/Article/196/547/67037.html</link><description>&lt;p&gt;&lt;img src="http://cdn.bizcommunity.com/c/1111/87237.jpg" alt="" width="70" height="23" align="left" &gt;&lt;i&gt;Legalbrief&lt;/i&gt; reports that the North Gauteng High Court has thrown out, on technical grounds, a bid to clarify what medical aid funds are required to pay for the treatment of a basic set of conditions, ranging from tuberculosis to malaria.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/547/67037.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=547&amp;ct=1&amp;ci=67037"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/547/67037.html</guid><pubDate>Fri, 11 Nov 2011 10:06:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Non-communicable diseases: Africa must 'spend a lot more'</title><link>http://www.bizcommunity.com/Article/196/573/66695.html</link><description>&lt;p&gt;&lt;img src="http://cdn.bizcommunity.com/c/1111/86606.jpg" alt="" width="70" height="70" align="left" &gt;BERLIN, GERMANY: According to &lt;i&gt;scidev.net&lt;/i&gt;, Olive Shisana, CEO of the South African Human Sciences Research Council, said at the World Health Summit in Berlin, Germany that infectious diseases, such as tuberculosis and HIV/AIDS, are expected to decline while non-communicable diseases, including cardiovascular disease, cancer and diabetes, will increase in Africa over the coming decades.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/573/66695.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=573&amp;ct=1&amp;ci=66695"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/573/66695.html</guid><pubDate>Fri, 04 Nov 2011 11:47:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Spotlight on malaria, indoor residual spraying</title><link>http://www.bizcommunity.com/Article/196/152/65594.html</link><description>&lt;p&gt;The inclusion of indoor residual spraying (IRS) in comprehensive malaria control programs is the focus of an international private sector workshop being convened by GBCHealth and the Roll Back Malaria partnership (RBM). The workshop seeks to expand public-private partnerships for malaria control, particularly IRS, in efforts to end malaria deaths in Africa and elsewhere.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/65594.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=65594"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/65594.html</guid><pubDate>Thu, 13 Oct 2011 07:50:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Keeping a measure on malaria</title><link>http://www.bizcommunity.com/Article/196/152/64641.html</link><description>&lt;p&gt;NEW YORK: The African Leaders Malaria Alliance (ALMA) has launched a scorecard to improve the fight against malaria on the African continent.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/64641.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=64641"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/64641.html</guid><pubDate>Fri, 23 Sep 2011 15:53:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Results of medication studies in top medical journals may be misleading to readers</title><link>http://www.bizcommunity.com/Article/196/323/63338.html</link><description>&lt;p&gt;A UCLA-Harvard study has highlighted three types of confusing outcome measures. Studies about medications published in the most influential medical journals are frequently designed in a way that yields misleading or confusing results, new research suggests.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/323/63338.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=323&amp;ct=1&amp;ci=63338"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/323/63338.html</guid><pubDate>Fri, 26 Aug 2011 09:19:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>DNDi launches new HIV/AIDS drug development programme for children</title><link>http://www.bizcommunity.com/Article/196/153/61894.html</link><description>&lt;p&gt;&lt;img src="http://cdn.bizcommunity.com/c/1107/77756.jpg" alt="" width="70" height="70" align="left" &gt;Yesterday at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, the Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV and AIDS.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/153/61894.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=153&amp;ct=1&amp;ci=61894"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/153/61894.html</guid><pubDate>Wed, 20 Jul 2011 10:37:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Kingsley Holgate off to Sudan</title><link>http://www.bizcommunity.com/Article/196/152/60820.html</link><description>&lt;p&gt;This morning, Nando&apos;s founder Robert Brozin, helped launch &quot;A Journey to Juba&quot;, the most recent expedition by adventurer, Kingsley Holgate, to distribute mosquito nets in Africa.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/60820.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=60820"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/60820.html</guid><pubDate>Tue, 21 Jun 2011 13:04:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>KENYA: Marginal profits hamper malaria drug subsidy</title><link>http://www.bizcommunity.com/Article/196/152/59738.html</link><description>&lt;p&gt;NAIROBI: On the streets of Nairobi, James Odhiambo goes from one pharmacy to the next in search of anti-malarial drugs marked with the Global Fund&apos;s logo of a green leaf. He is looking for this specific brand because he understands that it is more than ten times cheaper than the same drug produced by different manufacturers.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/59738.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=59738"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/59738.html</guid><pubDate>Fri, 20 May 2011 13:54:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Help MSF 'Kiss Malaria Goodbye!'</title><link>http://www.bizcommunity.com/Article/196/152/59250.html</link><description>&lt;p&gt;&lt;img src="http://cdn.bizcommunity.com/c/1105/72059.jpg" alt="" width="53" height="70" align="left" &gt;Doctors Without Border (Medecins sans Frontieres / MSF) is in the middle of its Kiss Malaria Good Bye Campaign. This on-line and mobile awareness and fundraising campaign will see funds used for medical humanitarian care to over 9 million patients MSF doctors and nurses care for in more than 65 countries around the world, including 1 million malaria patients, the majority of them in Africa.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/59250.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=59250"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/59250.html</guid><pubDate>Thu, 05 May 2011 14:10:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item><item><title>Transgenic fungal approach can fight against malaria and bug-borne diseases</title><link>http://www.bizcommunity.com/Article/196/152/57165.html</link><description>&lt;p&gt;&lt;img src="http://cdn.bizcommunity.com/c/1102/67212.jpg" alt="" width="70" height="46" align="left" &gt;New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining.&lt;br&gt; &lt;a href="http://www.bizcommunity.com/Article/196/152/57165.html"&gt;Read more...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=152&amp;ct=1&amp;ci=57165"&gt;Send to a friend&lt;/a&gt;&lt;/p&gt;</description><guid>http://www.bizcommunity.com/Article/196/152/57165.html</guid><pubDate>Fri, 25 Feb 2011 12:15:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/152.html</source></item></channel></rss>
